GILEAD SCIENCES, INC. PP&E Net 2008-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current pp&e net?
GILEAD SCIENCES, INC. (GILD) annual pp&e net for 2025 was $5.61B, a 3.55% increase from 2024. GILEAD SCIENCES, INC. pp&e net for the quarter ending March 31, 2026 was $5.64B.
What was GILEAD SCIENCES, INC.'s pp&e net in 2024?
GILEAD SCIENCES, INC. annual pp&e net for 2024 was $5.41B, a 1.82% increase from 2023.
What was GILEAD SCIENCES, INC.'s pp&e net in 2023?
GILEAD SCIENCES, INC. annual pp&e net for 2023 was $5.32B, a 2.89% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year pp&e net CAGR?
GILEAD SCIENCES, INC. pp&e net grew at a compound annual growth rate (CAGR) of 2.45% from FY2020 to FY2025, going from $4.97B to $5.61B over 5 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.4%
FY2020
$4.97B
→
FY2025
$5.61B
080910111213141516171819202122232425
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.61B | +3.5% | 10-K |
| FY2024 | $5.41B | +1.8% | 10-K |
| FY2023 | $5.32B | -2.9% | 10-K |
| FY2022 | $5.47B | +6.9% | 10-K |
| FY2021 | $5.12B | +3.1% | 10-K |
| FY2020 | $4.97B | +10.3% | 10-K |
| FY2019 | $4.50B | +12.4% | 10-K |
| FY2018 | $4.01B | +21.6% | 10-K |
| FY2017 | $3.29B | +15.0% | 10-K |
| FY2016 | $2.87B | +25.9% | 10-K |
| FY2015 | $2.28B | +36.0% | 10-K |
| FY2014 | $1.67B | +43.6% | 10-K |
| FY2013 | $1.17B | +6.0% | 10-K |
| FY2012 | $1.10B | +42.1% | 10-K |
| FY2011 | $774.4M | +10.4% | 10-K |
| FY2010 | $701.2M | +0.2% | 10-K |
| FY2009 | $700.0M | +32.4% | 10-K |
| FY2008 | $528.8M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →